Genetic Insights Offer New Hope for Nonalcoholic Fatty Liver Disease Treatment

Cropped view of the sporty woman measuring waist with tape at bright kitchen. Weight loss and diet concept

Despite the prevalence of nonalcoholic fatty liver disease (NAFLD), the most common liver disease worldwide, there are currently no approved pharmacotherapies for NAFLD. This review explores the potential and challenges of using genetic findings to enhance and expedite the development of effective treatments for NAFLD.